An Examination of Predictors of Indicators of Response to Letrozole 2.5 mg
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Breast Cancer
Interventions: DRUG: letrozole 2.5 mg
Sponsor: University of Kansas